It has been shown that downregulation of mir-34a expression in mature glioma cells and human stem cells inhibits the expression of c-Met (tyrosine-protein kinase Met), Notch-1, and Notch-2 by binding them to the 3′-UTR mRNA domains. This evidence concerns the gene MET and central nervous system cancer.